Feb. 9, 2007 — Blockages in arteries that carry blood to the brain are clearly visible to physicians using contrast-enhanced magnetic resonance (MR) angiography, according to a study in the February issue of Radiology published by the Radiological Society of North America.

Eighty patients (44 men and 36 women) with suspected arterial occlusive disease were included in the study, which compared the performance of contrast-enhanced MR angiography to DSA and CT angiography. Two independent readers evaluated the images.

"Contrast-enhanced MR angiography provided highly accurate information about the supra-aortic arteries," said Kambiz Nael, M.D., research fellow and radiology resident at the David Geffen School of Medicine at UCLA in Los Angeles. "MR angiography produced results comparable to the gold standard of digital subtraction angiography (DSA) and multidetector computed tomography (CT) angiography. In addition, this technology produced images with higher resolution over a larger field of view in a shorter amount of time than previous contrast-enhanced MR angiography techniques," he said.

Blockages were detected with MR angiography in 208 segments of artery by the first reader and 218 by the second reader, correlating closely to the DSA and CT findings. In addition, MR angiography proved highly accurate (94 to 100 percent) for detecting blockages of over 50 percent, and image quality was rated sufficient to excellent for 97 percent of the arterial segments evaluated.

"MR angiography, using a small quantity of MRI dye injected into a vein in the arm, can produce detailed images of the arteries supplying the brain and can detect even minor degrees of narrowing or blockage. It does not involve exposure to x-rays and is widely regarded as a very safe, painless test," Dr. Nael said.

Dr. Nael predicts that in most cases, contrast-enhanced MR angiography could replace other diagnostic techniques for evaluation of all the arteries that supply blood to the brain.

"This procedure should be highly cost effective for clinical use, because of the speed and modest dose of contrast required," Dr. Nael said. "In the absence of contraindications to MRI, I would recommend MR angiography over DSA and CTA for routine use--avoiding increased risk of mini-stroke and radiation exposure."

"As the technology evolves, MR angiography will likely become even faster and more powerful," he said.


Related Content

News | PET Imaging

April 24, 2024 — A new study from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare ...

Time April 24, 2024
arrow
News | Radiology Business

April 23, 2024 — A diverse writing group—lead by authors at the University of Toronto—have developed an approach for ...

Time April 23, 2024
arrow
News | Radiology Business

April 17, 2024 — VISTA.AI announced the appointment of Daniel Hawkins as President and CEO. The company is pioneering AI ...

Time April 17, 2024
arrow
News | Radiology Business

April 4, 2024 — FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Time April 04, 2024
arrow
News | Molecular Imaging

March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...

Time March 29, 2024
arrow
News | FDA

March 27, 2024 — SyntheticMR announced that its next-generation imaging solution, SyMRI 3D, has received FDA 510(k) ...

Time March 27, 2024
arrow
News | Artificial Intelligence

March 1, 2024 — Royal Philips, a global leader in health technology, and magnetic resonance imaging (MRI) software ...

Time March 01, 2024
arrow
News | Cardiac Imaging

February 12, 2024 — According to the American Journal of Roentgenology (AJR), free-breathing cine-deep learning (DL) may ...

Time February 12, 2024
arrow
News | Radiology Business

January 25, 2024 — Esaote Group, a leading Italian innovator in medical imaging, today unveiled its new brand identity ...

Time January 25, 2024
arrow
News | Artificial Intelligence

January 23, 2024 — Quibim announced it has added an industry-leading cancer detection capability to its prostate tool ...

Time January 22, 2024
arrow
Subscribe Now